A Clinical Study of TQB2618 Injection Monotherapy and Combination Regimen (With Penpulimab Injection ±Anlotinib Hydrochloride Capsules) in the Four or Later Lines of Treatment of Advanced Colorectal Cancer.

NCT06010901 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

75

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: TQB2618 injection
DRUG: Penpulimab injection
DRUG: Anlotinib hydrochloride capsules

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.